Literature DB >> 20451447

Success through diversity - how Staphylococcus epidermidis establishes as a nosocomial pathogen.

Sonja M K Schoenfelder1, Claudia Lange, Martin Eckart, Susanne Hennig, Svitlana Kozytska, Wilma Ziebuhr.   

Abstract

Staphylococcus epidermidis normally is a commensal inhabitant of the healthy human skin and mucosa, but also a common nosocomial pathogen in immunocompromised patients. Living at the edge between commensalism and pathogenicity, S. epidermidis has developed interesting strategies to conquer the hospital environment as a novel ecological niche and to transform into a notorious pathogen. Recent progress in genome analysis and molecular epidemiology gave interesting insights into the enormous flexibility by which these bacteria generate continuously novel phenotypic and genotypic variants. Recent multilocus sequence typing studies identified S. epidermidis as a highly diverse species that evolves mainly by recombination and acquires readily mobile genetic elements. With respect to healthcare-associated isolates, a limited number of epidemic clonal lineages were found to have emerged and established in hospital settings worldwide. These isolates are characterised by the carriage of various SCCmec gene cassettes, conferring methicillin resistance, and by a striking ability to form biofilms on medical devices. Moreover, nosocomial S. epidermidis strains typically harbour multiple copies of the insertion sequence element IS256 in their genomes. Nosocomial S. epidermidis strains vary virulence- and resistance-associated gene expression in the course of an infection to a remarkably high degree. Heterogenous gene expression in S. epidermidis is achieved, on the one hand, by complex regulatory pathways. On the other hand, it is associated with genetic mechanisms that were found to be mediated by the action of the IS256 element which obviously represents an important driving force for the flexibility of the S. epidermidis genome. The data accumulated so far suggest that recombination along with the frequent acquisition of mobile genetic elements are crucial factors for the success of S. epidermidis as a nosocomial pathogen. Copyright 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20451447     DOI: 10.1016/j.ijmm.2010.04.011

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  47 in total

1.  A multidrug-resistant Staphylococcus epidermidis clone (ST2) is an ongoing cause of hospital-acquired infection in a Western Australian hospital.

Authors:  Micael Widerström; Cheryll A McCullough; Geoffrey W Coombs; Tor Monsen; Keryn J Christiansen
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

2.  Molecular Epidemiology of a Vancomycin-Intermediate Heteroresistant Staphylococcus epidermidis Outbreak in a Neonatal Intensive Care Unit.

Authors:  Jasmine Chong; Caroline Quach; Ana C Blanchard; Philippe Guillaume Poliquin; George R Golding; Céline Laferrière; Simon Lévesque
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 3.  Mastitis: comparative etiology and epidemiology.

Authors:  G Andres Contreras; Juan Miguel Rodríguez
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-09-27       Impact factor: 2.673

4.  Distribution of oral mucosal bacteria with mecA in patients undergoing hematopoietic cell transplantation.

Authors:  Takayuki Ebinuma; Yoshihiko Soga; Takamaro Sato; Kazuyuki Matsunaga; Chieko Kudo; Hiroshi Maeda; Yoshinobu Maeda; Mitsune Tanimoto; Shogo Takashiba
Journal:  Support Care Cancer       Date:  2014-02-19       Impact factor: 3.603

Review 5.  Coagulase-negative staphylococci.

Authors:  Karsten Becker; Christine Heilmann; Georg Peters
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.

Authors:  Rodrigo E Mendes; Lalitagauri M Deshpande; Andrew J Costello; David J Farrell
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

Review 7.  Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus.

Authors:  M Widerström; J Wiström; A Sjöstedt; T Monsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

8.  Staphylococcus epidermidis pan-genome sequence analysis reveals diversity of skin commensal and hospital infection-associated isolates.

Authors:  Sean Conlan; Lilia A Mijares; Jesse Becker; Robert W Blakesley; Gerard G Bouffard; Shelise Brooks; Holly Coleman; Jyoti Gupta; Natalie Gurson; Morgan Park; Brian Schmidt; Pamela J Thomas; Michael Otto; Heidi H Kong; Patrick R Murray; Julia A Segre
Journal:  Genome Biol       Date:  2012-07-25       Impact factor: 13.583

9.  Biofilm-degrading enzymes from Lysobacter gummosus.

Authors:  Anke Gökçen; Andreas Vilcinskas; Jochen Wiesner
Journal:  Virulence       Date:  2014-02-11       Impact factor: 5.882

10.  Surveillance of antimicrobial resistance among clinical isolates recovered from a tertiary care hospital in Al Qassim, Saudi Arabia.

Authors:  Kamaleldin B Said; Ahmed N Al-Jarbou; Mohammed Alrouji; Hajed O Al-Harbi
Journal:  Int J Health Sci (Qassim)       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.